SCHEDULE: BlackRock Discloses Stake in iRhythm Technologies
Beneficial Ownership Filing
BlackRock, Inc. has filed a Schedule 13G, reporting beneficial ownership of 5.01% of iRhythm Technologies' common stock as of June 30, 2026.
Summary
- BlackRock, Inc. has filed a Schedule 13G, indicating it beneficially owns 641,128 shares of IRADIMED CORP common stock.
- This ownership represents 5.01% of the class of securities.
- The filing date for this event is June 30, 2026.
- BlackRock, Inc. has sole voting power over 622,925 shares and sole dispositive power over 641,128 shares.
- The filing is made in accordance with Rule 13d-1(b) and BlackRock, Inc. is classified as a 'HC' (likely referring to a holding company or similar entity) type of reporting person.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it is a routine disclosure of beneficial ownership by an institutional investor and does not contain operational or financial performance updates.
Positives
- BlackRock, Inc., a significant institutional investor, has disclosed a substantial ownership stake, which can be viewed positively by the market.
- The ownership stake of 5.01% indicates a notable investment in IRADIMED CORP.
Future Outlook
This filing is a disclosure of current ownership and does not contain forward-looking statements or guidance regarding future performance.
Industry Context
StockSavvy.ai notes that Schedule 13G filings by large institutional investors like BlackRock often signal confidence in a company's long-term prospects or a strategic rebalancing of portfolios. The 5.01% stake in IRADIMED CORP is a significant position for an institutional holder.
Stakeholder Impact
- Shareholders may view BlackRock's increased stake as a positive signal of institutional confidence in IRADIMED CORP.
- The filing itself does not directly impact employees, customers, suppliers, or creditors.
Next Steps
- BlackRock, Inc. will continue to hold or manage its investment in IRADIMED CORP.
- Further filings may be required if BlackRock's ownership stake changes significantly.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of Power of Attorney for BlackRock, Inc. |
| 04/30/2023 | Previous Power of Attorney revoked by BlackRock, Inc. |
| 06/30/2026 | Date of Event Requiring Filing of Schedule 13G |
| 07/28/2026 | Date of Signature on Schedule 13G |
Keywords
IRADIMED CORP, Schedule 13G, BlackRock, Beneficial Ownership, Common Stock, Institutional Investor, Securities Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.